Enveric Biosciences ENVB
NASDAQ ENVB
$1.43 +0.04 (+2.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enveric Biosciences (ENVB) Goodwill & Intangibles (2015 - 2024)

Enveric Biosciences (ENVB) posted Goodwill & Intangibles of $42182.0 for Q4 2024, down 50.0% sequentially from $84368.0 in Q3 2024, and down 80.0% YoY from $210932.0 in Q1 2024.

Enveric Biosciences (ENVB) Goodwill & Intangibles (2015 - 2024) Analysis & Trends

Enveric Biosciences has reported Goodwill & Intangibles for 10 years, with the latest figure at $42182.0 in Q4 2024.

  • Quarterly Goodwill & Intangibles fell 80.0% year-over-year to $42182.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $42182.0 (down 80.0% YoY) and the FY2024 annual result came in at $42182.0, down 80.0% from the prior year.
  • Goodwill & Intangibles declined to $42182.0 in Q4 2024 per ENVB's latest filing, from $84368.0 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $47.9 million in Q3 2021 and troughed at $42182.0 in Q4 2024.
  • A 5-year average of $6.9 million and a median of $2.0 million in 2020 frame the typical range for Goodwill & Intangibles.
  • The sharpest annual moves came in 2021 and 2023: Goodwill & Intangibles surged 338.08% in 2021, then slumped 93.13% in 2023.
  • Over 5 years, Goodwill & Intangibles stood at $1.8 million in 2020, then soared by 338.08% to $8.0 million in 2021, then slumped by 90.46% to $759372.0 in 2022, then tumbled by 72.22% to $210932.0 in 2023, then slumped by 80.0% to $42182.0 in 2024.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $42182.0, $84368.0, and $126556.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Enveric Biosciences 5.66 Mn -2.64 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 42,182.00
Sep 30, 2024 84,368.00
Jun 30, 2024 126,556.00
Mar 31, 2024 168,744.00
Dec 31, 2023 210,932.00
Sep 30, 2023 506,240.00
Jun 30, 2023 590,622.00
Mar 31, 2023 674,996.00
Dec 31, 2022 759,372.00
Sep 30, 2022 7.37 Mn
Jun 30, 2022 7.83 Mn
Mar 31, 2022 8.59 Mn
Dec 31, 2021 7.96 Mn
Sep 30, 2021 47.93 Mn
Jun 30, 2021 2.19 Mn
Mar 31, 2021 2.36 Mn
Dec 31, 2020 1.82 Mn
Sep 30, 2020 15.68 Mn
Jun 30, 2020 16.22 Mn
Mar 31, 2020 16.77 Mn